Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NF-kappa B: a new player in angiostatic therapy.
Tabruyn SP, Griffioen AW. Tabruyn SP, et al. Angiogenesis. 2008;11(1):101-6. doi: 10.1007/s10456-008-9094-4. Epub 2008 Feb 19. Angiogenesis. 2008. PMID: 18283548 Free PMC article. Review.
A new role for NF-kappaB in angiogenesis inhibition.
Tabruyn SP, Griffioen AW. Tabruyn SP, et al. Cell Death Differ. 2007 Aug;14(8):1393-7. doi: 10.1038/sj.cdd.4402156. Epub 2007 Apr 27. Cell Death Differ. 2007. PMID: 17464324 No abstract available.
Angiostatic activity of the antitumor cytokine interleukin-21.
Castermans K, Tabruyn SP, Zeng R, van Beijnum JR, Eppolito C, Leonard WJ, Shrikant PA, Griffioen AW. Castermans K, et al. Among authors: tabruyn sp. Blood. 2008 Dec 15;112(13):4940-7. doi: 10.1182/blood-2007-09-113878. Epub 2008 May 30. Blood. 2008. PMID: 18515660 Free PMC article.
Molecular pathways of angiogenesis inhibition.
Tabruyn SP, Griffioen AW. Tabruyn SP, et al. Biochem Biophys Res Commun. 2007 Mar 30;355(1):1-5. doi: 10.1016/j.bbrc.2007.01.123. Epub 2007 Jan 30. Biochem Biophys Res Commun. 2007. PMID: 17276388 Review.
Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity.
Wentink MQ, Hackeng TM, Tabruyn SP, Puijk WC, Schwamborn K, Altschuh D, Meloen RH, Schuurman T, Griffioen AW, Timmerman P. Wentink MQ, et al. Among authors: tabruyn sp. Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):12532-12537. doi: 10.1073/pnas.1610258113. Epub 2016 Oct 17. Proc Natl Acad Sci U S A. 2016. PMID: 27791128 Free PMC article.
PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin.
Bajou K, Herkenne S, Thijssen VL, D'Amico S, Nguyen NQ, Bouché A, Tabruyn S, Srahna M, Carabin JY, Nivelles O, Paques C, Cornelissen I, Lion M, Noel A, Gils A, Vinckier S, Declerck PJ, Griffioen AW, Dewerchin M, Martial JA, Carmeliet P, Struman I. Bajou K, et al. Nat Med. 2014 Jul;20(7):741-7. doi: 10.1038/nm.3552. Epub 2014 Jun 15. Nat Med. 2014. PMID: 24929950
Intrinsic pro-angiogenic status of cystic fibrosis airway epithelial cells.
Verhaeghe C, Tabruyn SP, Oury C, Bours V, Griffioen AW. Verhaeghe C, et al. Among authors: tabruyn sp. Biochem Biophys Res Commun. 2007 May 11;356(3):745-9. doi: 10.1016/j.bbrc.2007.02.166. Epub 2007 Mar 16. Biochem Biophys Res Commun. 2007. PMID: 17382901 Free article.
Corrigendum: PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin.
Bajou K, Herkenne S, Thijssen VL, D'Amico S, Nguyen NQ, Bouché A, Tabruyn S, Srahna M, Carabin JY, Nivelles O, Paques C, Cornelissen I, Lion M, Noel A, Gils A, Vinckier S, Declerck PJ, Griffioen AW, Dewerchin M, Martial JA, Carmeliet P, Struman I. Bajou K, et al. Nat Med. 2015 May;21(5):537. doi: 10.1038/nm0515-537a. Nat Med. 2015. PMID: 25951534 No abstract available.
37 results